PRESENTATION · Nov 2025 · PDF

Acoramidis-AHA 2025- Variant ACM and First CVH

PRESENTATION · Nov 2025 · PDF

Acoramidis -AHA 2025- p.V142I (V122I) ACM analysis

PRESENTATION · Nov 2025 · PDF

Acoramidis -AHA 2025- NT-proBNP and Atrial Fibrillation

PRESENTATION · Nov 2025 · PDF

Acoramidis-AHA 2025- ACM and CVH (early HF with and without AF)

PRESENTATION · Nov 2025 · PDF

Acoramidis-AHA 2025- VA Prevalence Geographic Disparities

PRESENTATION · Nov 2025 · PDF

Acoramidis-AHA 2025- Demographic Disparities

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-VA-Incidence-of-ATTR-CM-by-State

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-Effect-on-CVM_Recurrent-CVH-Cumulative-Incidence-Oral-Presentation

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-NT-proBNP-in-ATTRv-CM

PRESENTATION · Sep 2025 · PDF

Acoramidis-HFSA-2025-OLE-ACM-and-CVH-by-Genotype